Brief: Lisata Therapeutics Receives Paediatric Investigation Plan Waiver From European Medicines Agency
20/05/2024 14:22
May 20 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS RECEIVES PAEDIATRIC INVESTIGATION PLAN
WAIVER FROM THE EUROPEAN MEDICINES AGENCY FOR CERTEPETIDE IN
PANCREATIC CANCER
* LISATA THERAPEUTICS INC - WAIVER CONFIRMS THAT PAEDIATRIC
STUDIES OF CERTEPETIDE IN PANCREATIC CANCER ARE NOT NEEDED
Source text for Eikon: ID:nGNX8cwg5b
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco